Headstart: A COVID-19 vaccine from South Korea is displaying promising outcomes after it yielded a 91-95% efficacy charge in its section 1 and a pair of scientific trials. Mixed section 2 and section 3 scientific trials for EuCorVac-19 are scheduled to start within the Philippines this month.
For extra ANC interviews, click on the hyperlink under:
For extra COVID-19 movies, click on the hyperlink under:
For extra Dateline Philippines movies, click on the hyperlink under:
Subscribe to the ANC Youtube channel!
Go to our web site at